NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Then of course begging the question: Why has the company elected to first submit their marketing authorization application in the UK rather than to the FDA?

But lifting it does telegraph something... IMO... that the reason for the halt was not a bad one, and instead, as you, DocLogic and others often contend, rather an indication of DCVax-L efficacy, meaning... the vaccine works